Substituted 5-membered ring compounds and their use

Details Substituted 5-membered ring compounds and their use Substituted 5-membered ring compounds and their use

2004-06-24

2010-06-01

Chu, Yong (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S255000

Reexamination Certificate

active

07728016

ABSTRACT:
Compound of a compound of formula (I) or a salt, N-oxide, hydrate or solvate thereof, in the preparation of a composition for inhibition of HSP90 activity: wherein ring A is an aromatic or non-aromatic carbocyclic or heterocyclic ring having 5 ring atoms, for example 1,2,3-triazolyl or a 1,2,4-triazolyl or a tetrazolyl ring; and R1R2R3are as defined in the specification are inhibitors of HSP90 and therefore of use in the treatment of, for example, cancers, viral disease, inflammatory diseases such as rheumatoid arthritis, asthma, multiple sclerosis, Type I diabetes, lupus, psoriasis and inflammatory bowel disease; cystic fibrosis angiogenesis-related disease such as diabetic retinopathy, haemangiomas, and endometriosis; or for protection of normal cells against chemotherapy-induced toxicity; or diseases where failure to undergo apoptosis is an underlying factor, or protection from hypoxia-ischemic injury due to elevation of Hsp70 in the heart and brain; scrapie/CJD, Huntingdon's and Alzheimer's disease.

REFERENCES:
patent: 5489598 (1996-02-01), Connor et al.
patent: 5869509 (1999-02-01), Gribkoff et al.
patent: 4320801 (1995-01-01), None
patent: 1 070 708 (2001-01-01), None
patent: 1 293 503 (2003-03-01), None
patent: 2 258 180 (1975-08-01), None
patent: 1 406 345 (1975-09-01), None
patent: 99-40088 (1999-08-01), None
patent: 99-64415 (1999-12-01), None
patent: 01-07436 (2001-02-01), None
patent: 01-34198 (2001-05-01), None
patent: 01-34580 (2001-05-01), None
patent: 03-015777 (2003-02-01), None
patent: 03-101985 (2003-12-01), None
patent: 03-104207 (2003-12-01), None
patent: 2004-030611 (2004-04-01), None
Abstract of Afinidad (1993), 50(447), pp. 316-318, from STN search report.
Medaer et al., Tetrahedron, 1997, 52(26), pp. 8813-8826.
Vippagunta et al., Advanced Drug Delivery Reviews, p. 1.
Fevig John M. et al: “Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core” Bioorganic and Medicinal Chemistry Letters, vol. 11, No. 5, Mar. 12, 2001, XP002301746, ISSN: 0960-894X.

Affiliated with

Also associated with

Rating

Substituted 5-membered ring compounds and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted 5-membered ring compounds and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 5-membered ring compounds and their use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4250544